» Articles » PMID: 15204018

Use of Noninvasive Ventilation in Patients with Amyotrophic Lateral Sclerosis

Overview
Specialty Neurology
Date 2004 Jun 19
PMID 15204018
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Noninvasive positive pressure ventilation (NIPPV) is associated with improved survival in amyotrophic lateral sclerosis (ALS) and has been widely recommended. The extent of NIPPV use in ALS patients and the factors associated with its use have not been studied.

Methods: A cross-sectional study using the ALS Patient Care Database. Analyses were performed to assess the association of patient and care characteristics with use of ventilatory support.

Results: 1458 patients were studied. 15.6% used NIPPV and 2.1% used invasive mechanical ventilation. Patients who used NIPPV were significantly more likely to be male and have higher income than those who did not. They were also more likely to have a gastrostomy tube, lower vital capacity, more severe disease, bulbar involvement and poorer general health status as measured by the SF-12 and Sickness Impact Profile. Multivariate analysis revealed that lower FVC, higher income and use of gastrostomy tube were independently associated with use of NIPPV.

Conclusions: NIPPV is used more than seven times as frequently as invasive ventilation in ALS patients. Patients who use NIPPV have more severe disease than those who do not use any respiratory intervention. Patients with lower income are less likely to use NIPPV, which raises concerns about disparities in the care of patients with ALS.

Citing Articles

Factors associated with assisted ventilation use in amyotrophic lateral sclerosis: a nationwide population-based study in Korea.

Yoon S, Kim H, Kim M, Suh J, Leigh J Sci Rep. 2021; 11(1):19682.

PMID: 34608192 PMC: 8490422. DOI: 10.1038/s41598-021-98990-x.


Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients' perspectives.

Greenaway L, Martin N, Lawrence V, Janssen A, Al-Chalabi A, Leigh P J Neurol. 2015; 262(4):1002-13.

PMID: 25683760 DOI: 10.1007/s00415-015-7665-z.


Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Gordon P Aging Dis. 2013; 4(5):295-310.

PMID: 24124634 PMC: 3794725. DOI: 10.14336/AD.2013.0400295.


Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study.

Bae J, Hong Y, Baek W, Sohn E, Cho J, Kim B J Clin Neurol. 2013; 8(4):293-300.

PMID: 23323138 PMC: 3540289. DOI: 10.3988/jcn.2012.8.4.293.


Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Gordon P CNS Drugs. 2010; 25(1):1-15.

PMID: 21128691 DOI: 10.2165/11586000-000000000-00000.